Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP

R-CHOP is an effective first-line treatment for patients with FLG3, and might provide extended PFS, comparable with outcomes observed in diffuse large B-cell lymphoma, particularly in subgroups with limited nodal disease.